1. Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine and Faculty of Science, University of Ostrava, Poruba, Czech Republic;
2. 4th Department of Internal Medicine – Hematology, Charles University Faculty Hospital and Faculty of Medicine, Hradec Králové, Czech Republic;
3. Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Jihlavská 340/20, 625 00 Brno-Bohunice-Brno-Starý Lískovec, Czech Republic;
4. Department of Internal Medicine, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Hradec Králové, Czech Republic;
5. Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic;
6. Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Praha, Czech Republic;
7. Department of Hematology and Transfusion Medicine, Pelhrimov Hospital, Pelhřimov, Czech Republic;
8. Department of Clinical Hematology, Hospital Ceske Budejovice, České Budějovice, Czech Republic;
9. Department of Hematology, General Hospital Liberec, Liberec, Czech Republic;
10. Department of Clinical Hematology, Silesian Hospital Opava, Opava, Czech Republic;
11. Department of Hematology, Hospital Novy Jicin, Nový Jičín, Czech Republic;
12. Department of Clinical Hematology, General Hospital Havirov, Havířov, Czech Republic;
13. Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Republic;
14. Janssen Health Economics & Market Access EMEA Statistics & Modelling, Beerse, Belgium;
15. Janssen Health Economics & Market Access EMEA, Athens, Greece;
16. Janssen – Cilag s.r.o., Smíchov-Anděl, Czech Republic;
17. Janssen Health Economics & Market Access EMEA, High Wycombe, UK;
18. Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic